These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9572543)

  • 21. Retinal capillary dilation: early diabetic-like retinopathy in the galactose-fed rat model.
    Glover JP; Jacot JL; Basso MD; Hohman TC; Robison WG
    J Ocul Pharmacol Ther; 2000 Apr; 16(2):167-72. PubMed ID: 10803427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetic-like retinopathy: early and late intervention therapies in galactose-fed rats.
    Robison WG; Jacot JL; Glover JP; Basso MD; Hohman TC
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1933-41. PubMed ID: 9727416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycolytic pathway, redox state of NAD(P)-couples and energy metabolism in lens in galactose-fed rats: effect of an aldose reductase inhibitor.
    Obrosova I; Faller A; Burgan J; Ostrow E; Williamson JR
    Curr Eye Res; 1997 Jan; 16(1):34-43. PubMed ID: 9043821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aldose reductase inhibitor counteracts the enhanced expression of matrix metalloproteinase-10 and improves corneal wound healing in galactose-fed rats.
    Takamura Y; Matsumoto T; Tomomatsu T; Matsumura T; Takihara Y; Inatani M
    Mol Vis; 2013; 19():2477-86. PubMed ID: 24339723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetic-like retinopathy ameliorated with the aldose reductase inhibitor WAY-121,509.
    Robinson WG; Laver NM; Jacot JL; Glover JP; Basso MD; Blouin P; Hohman TC
    Invest Ophthalmol Vis Sci; 1996 May; 37(6):1149-56. PubMed ID: 8631629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia.
    Frank RN; Amin R; Kennedy A; Hohman TC
    Arch Ophthalmol; 1997 Aug; 115(8):1036-47. PubMed ID: 9258227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Morphological classification of the prevention by aldose reductase inhibitor of rat galactosemic cataract].
    Akagi Y; Ikebe H; Terubayashi H; Takahashi Y; Tsuji T
    Nippon Ganka Gakkai Zasshi; 1989 Apr; 93(4):494-500. PubMed ID: 2508449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normalization of lens protein kinase Cgamma in galactosemic dogs by a novel aldose reductase inhibitor.
    Takemoto DJ; Harris R; Brightman A; McGill J; Hua D; Davidson H; Fenwick B; Wagner LM
    Vet Ophthalmol; 2004; 7(3):163-7. PubMed ID: 15091323
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rat kidney aldose reductase and aldehyde reductase and polyol production in rat kidney.
    Sato S
    Am J Physiol; 1992 Nov; 263(5 Pt 2):F799-805. PubMed ID: 1443170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effects of chlorogenic acid on aldose reductase activity in vitro and cataractogenesis in galactose-fed rats.
    Kim CS; Kim J; Lee YM; Sohn E; Jo K; Kim JS
    Arch Pharm Res; 2011 May; 34(5):847-52. PubMed ID: 21656371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Minimal effects of two aldose reductase inhibitors, AL-1576 and AL-4114, after subacute topical-ocular dosing on xenobiotic biotransformation in rabbits.
    Sastry SG; Sanders RA; Veltman JC; Watkins JB
    Drug Metab Dispos; 1995 Oct; 23(10):1094-8. PubMed ID: 8654197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo activities of aldose reductase inhibitors having a 1-(arylsulfonyl)hydantoin structure.
    Miwa I; Hirano M; Kanbara M; Okuda J
    Biochem Pharmacol; 1990 Jul; 40(2):303-7. PubMed ID: 2115779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
    Unakar N; Tsui J; Johnson M
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Galactose-induced retinal microangiopathy in rats.
    Kern TS; Engerman RL
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):490-6. PubMed ID: 7843917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and evaluation of novel aldose reductase inhibitors: Effects on lens protein kinase Cgamma.
    Lewis S; Karrer J; Saleh S; Chan X; Tan Z; Hua D; McGill J; Pang YP; Fenwick B; Brightman A; Takemoto D
    Mol Vis; 2001 Jul; 7():164-71. PubMed ID: 11483892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of naphthalene cataract in rats by aldose reductase inhibitors.
    Lou MF; Xu GT; Zigler S; York B
    Curr Eye Res; 1996 Apr; 15(4):423-32. PubMed ID: 8670742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Permeability changes in blood-retinal barrier of galactosemic rats are prevented by aldose reductase inhibitors.
    Lightman S; Rechthand E; Terubayashi H; Palestine A; Rapoport S; Kador P
    Diabetes; 1987 Nov; 36(11):1271-5. PubMed ID: 3117606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antioxidant potential of fungal metabolite nigerloxin during eye lens abnormalities in galactose-fed rats.
    Suresha BS; Srinivasan K
    Curr Eye Res; 2013 Oct; 38(10):1064-71. PubMed ID: 23767695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discordant effects of the aldose reductase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic rats.
    Tilton RG; Pugliese G; LaRose LS; Faller AM; Chang K; Province MA; Williamson JR
    J Diabet Complications; 1991; 5(4):230-7. PubMed ID: 1779018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of aldose reductase inhibitor, statil, on hyperpermeability of iridial vessels in experimental galactosemic rats.
    Terubayashi H; Akagi Y
    Jpn J Ophthalmol; 1989; 33(3):343-7. PubMed ID: 2507812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.